New search Hide text from Guidelines
N NERVOUS SYSTEMN04 ANTI-PARKINSON DRUGS
This group comprises preparations used in the treatment of Parkinsons disease and related conditions, including drug-induced parkinsonism.
The DDDs are based on recommended doses for the long-term treatment of symptoms of Parkinsons disease. No separate DDDs are established for oral depot formulations. |
N04A ANTICHOLINERGIC AGENTS
N04AB Ethers chemically close to antihistamines
Orphenadrine chloride is classified in this group, while orphenadrine citrate is classified in M03BC.
ATC code | Name | DDD | U | Adm.R | Note |
N04AB01 | etanautine |
Last updated: 2024-01-26